MN antigen expression in normal, preneoplastic, and neoplastic esophagus: A clinicopathological study of a new cancer-associated biomarker

Human Pathology

Volumn 28, Issue 6, 1997, Pages 740-744

  Turner, J R ^a,c   Odze, R D ^a,b   Crum, C P ^a   Resnick, M B ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

Adenocarcinoma; Barrett's esophagus; Esophagus; Immunohistochemistry; MN antigen; Squamous cell carcinoma

Indexed keywords

GLYCOPHORIN A; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BARRETT ESOPHAGUS; CELL PROLIFERATION; CELL REGENERATION; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PRECANCER; UTERINE CERVIX CARCINOMA;

EID: 0030972193     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90185-4     Document Type: Article

References (18)

1. Genest D, Stein L, Cibas E, et al: A binary (Bethesda) system for classifying cervical cancer precursors: Criteria, reproducibility and viral correlates. HUM PATHOL 24:730-736, 1993
2. Crum CP, Roche JK: Molecular pathology of the lower female genital tract: The papillomavirus model. Am J Surg Pathol 14:26-33, 1990
3. Liu F-S, Wang Q-L: in Ming SC, Goldman H (eds): Pathology of the Gastrointestinal Tract Philadelphia, PA, Saunders, 1992, pp 439-458
4. Cameron AJ, Lomboy CT, Pera M, et al: Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 109:1541-1546, 1995
5. Haggitt RC: Barrett's esophagus, dysplasia, and adenocarcinoma. HUM PATHOL 25:982-993, 1994
6. Stemmerman G, Heffelinger S, Noffsinger A, et al: The molecular biology of esophageal and gastric cancer and their precursors: Oncogenes, tumor suppressor genes, and growth factors. HUM PATHOL 25:968-981, 1994
7. Pera M, Cameron AJ, Trastek VF, et al: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104:510-513, 1993
8. Yang PC, Davis S: Incidence of cancer of the esophagus in the US by histologic type. Cancer 61:612-617, 1988
9. Zavada J, Zavadova Z, Pastorekova S, et al: Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54:268-274, 1993
10. Pastorek J, Pastorekova S, Callebaut I, et al: Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loophelix DNA binding segment. Oncogene 9:2877-2888, 1994
11. Pastorekova S, Zavadova Z, Kostal M, et al: A novel quasiviral agent, MaTu, is a two-component system. Virology 187:620-626, 1992
12. Costa MJ: MN and Ki67 (MIB-1) in uterine cervix carcinoma: Novel biomarkers with divergent utility. HUM PATHOL 27:217-218, 1996
13. Costa MJ, Ndoye A, Trelford JD: MN protein immunolocalization in uterine cervix carcinoma with glandular differentiation. Int J Surg Pathol 3:73-82, 1995
14. Liao SY, Brewer C, Zavada J, et al: Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 145:598-609, 1994
15. Resnick M, Lester S, Tate JE, et al: Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia. HUM PATHOL 27:234-239, 1996
16. Parkkila S, Parkkila AK, Juvonen T, et al: Distribution of the carbonic anhydrase isoenzymes I, II, and VI in the human alimentary tract. Gut 35:646-650, 1994
17. Shousha S, Pestonjee D: Distribution of carbonic anhydrase I in gastric and duodenal tissue sections. Arch Pathol Lab Med 111:279-281, 1987
18. Mori M, Staniunas RJ, Barnard GF, et al: The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 105:820-826, 1993